Quinn T Orb, Megan Pesch, Chelsea M Allen, Ashlea Wilkes, Iram Ahmad, Kristan Alfonso, Stephanie Moody Antonio, Leena Bhattacharya Mithal, Jennifer V Brinkmeier, Daniela Carvalho, Dylan Chan, Alan G Cheng, David Chi, Michael Cohen, Christopher Michael Discolo, Carlos Duran, John Germiller, Laura Gibson, Eli Grunstein, Gail Harrison, Kenneth Lee, Karen Hawley, Stephan Kohlhoff, Ann Melvin, Carol MacArthur, Michel Nassar, Laura Neff, Phayvanh Pecha, Christine Salvatore, Scott Schoem, Frank Virgin, James Saunders, Mark Schleiss, Richard J H Smith, Sunil Sood, Albert H Park
OBJECTIVE: To determine the positivity rate of congenital cytomegalovirus (cCMV) testing among universal, hearing-targeted CMV testing (HT-cCMV) and delayed targeted dried blood spot (DBS) testing newborn screening programs, and to examine the characteristics of successful HT-cCMV testing programs. STUDY DESIGN: Prospective survey of birth hospitals performing early CMV testing. SETTING: Multiple institutions. METHODS: Birth hospitals participating in the National Institutes of Health ValEAR clinical trial were surveyed to determine the rates of cCMV positivity associated with 3 different testing approaches: universal testing, HT-cCMV, and DBS testing...
February 28, 2024: Otolaryngology—Head and Neck Surgery